Oruka Therapeutics, Inc. Other Current Liabilities
Oruka Therapeutics, Inc. (ORKA) had Other Current Liabilities of $440.00 thousand as of 2015-06-30, per its 10-Q filed 2015-08-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2015-08-11
- 2015-06-30: Other Liabilities, Current $440.00K.
- 2015-03-31: Other Liabilities, Current $359.00K.
- 2014-12-31: Other Liabilities, Current $264.00K.
- 2014-09-30: Other Liabilities, Current $374.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2015-06-30 | $440.00K 10-Q · filed 2015-08-11 |
| 2015-03-31 | $359.00K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $264.00K 10-Q · filed 2015-08-11 |
| 2014-09-30 | $374.00K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $351.00K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $457.00K 10-Q · filed 2014-05-13 |
| 2013-12-31 | $446.00K 10-K · filed 2015-03-19 |
| 2013-09-30 | $247.00K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $257.00K 10-Q · filed 2013-08-13 |
| 2013-03-31 | $383.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $121.00K 10-K · filed 2014-03-20 |
| 2012-09-30 | $63.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $141.00K 10-Q · filed 2012-08-13 |
| 2012-03-31 | $357.00K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $350.00K 10-K · filed 2013-03-21 |
| 2011-09-30 | $270.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $339.00K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $506.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |